Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection

已完结 20 由 Jehiah 发布于 2026/9/14 14:10:33

DOI:10.1038/s41565-026-02188-z
作者：Zezhong Liu, Jie Zhou, Ruiyu Gao, Yanqun Wang, Meiqin Liu, Weijie Wang, Yuanzhou Wang, Peilan Wei, Kaicheng Zhou, Muzhuo Wang, Shaokun Pan, Lixia
文献类型：期刊论文
补充材料：仅需补充材料

Nature

Abstract：A major barrier in mucosal vaccine development is achieving localized immunity without systemic toxicity. Here we engineered NanoCF501, a nanoparticulate STING agonist formulated with a 2-et

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SageBiopolymer Hydroxypropyl Methylcellulose-Based Filaments Prepared by Hot-Melt Extrusion Suitable for Fused Deposition Modeling 3D Printing of Personalized Capsules.